Einträge von Wick, Wolfgang auf dem Publikationsserver
![]() | Eine Stufe nach oben |
Gehe zu: Artikel
Anzahl der Einträge: 26.
Artikel
Ippen, Franziska Maria
, Scherm, Angelika, Kessler, Tobias, Hau, Peter
, Agkatsev, Sarina, Baurecht, Hansjörg
, Wick, Wolfgang, Knüttel, Helge
, Leitzmann, Michael F.
und Seliger‐Behme, Corinna
(2024)
Targeted agents in patients with progressive glioblastoma—A systematic meta‐analysis of randomized clinical trials.
Cancer Medicine 13 (12), e7362.
Ippen, Franziska Maria
, Scherm, Angelika, Kessler, Tobias, Hau, Peter
, Baurecht, Hansjörg
, Wick, Wolfgang, Knüttel, Helge
, Leitzmann, Michael F.
und Seliger, Corinna
(2023)
Targeted agents in patients with recurrent glioblastoma– a systematic meta-analysis of randomized clinical trials.
Neuro-Oncology 25 (Supp.5), v116.
Scherm, Angelika, Ippen, Franziska Maria
, Hau, Peter, Baurecht, Hansjörg
, Wick, Wolfgang, Gempt, Jens
, Knüttel, Helge
, Leitzmann, Michael
und Seliger, Corinna
(2023)
Targeted therapies in patients with newly diagnosed glioblastoma - a systematic meta-analysis of randomized clinical trials.
International journal of cancer, (early view).
Hertler, Caroline, Felsberg, Jörg, Gramatzki, Dorothee
, Le Rhun, Emilie, Clarke, Jennifer
, Soffietti, Riccardo, Wick, Wolfgang
, Chinot, Olivier, Ducray, François, Roth, Patrick, McDonald, Kerrie, Hau, Peter, Hottinger, Andreas F., Reijneveld, Jaap, Schnell, Oliver, Marosi, Christine, Glantz, Michael, Darlix, Amélie, Lombardi, Giuseppe, Krex, Dietmar, Glas, Martin, Reardon, David A., van den Bent, Martin
, Lefranc, Florence, Herrlinger, Ulrich, Razis, Evangelia, Carpentier, Antoine F., Phillips, Samuel, Rudà, Roberta, Wick, Antje
, Tabouret, Emeline, Meyronet, David, Maurage, Claude-Alain, Rushing, Elisabeth, Rapkins, Robert, Bumes, Elisabeth, Hegi, Monika, Weyerbrock, Astrid, Aregawi, Dawit, Gonzalez-Gomez, Christian, Pellerino, Alessia
, Klein, Martin, Preusser, Matthias
, Bendszus, Martin, Golfinopoulos, Vassilis, von Deimling, Andreas, Gorlia, Thierry, Wen, Patrick Y., Reifenberger, Guido und Weller, Michael
(2023)
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419).
European Journal of Cancer 189, S. 112913.
Volltext nicht vorhanden.
, Le Rhun, Emilie, Clarke, Jennifer
, Soffietti, Riccardo, Wick, Wolfgang
, Chinot, Olivier, Ducray, François, Roth, Patrick, McDonald, Kerrie, Hau, Peter, Hottinger, Andreas F., Reijneveld, Jaap, Schnell, Oliver, Marosi, Christine, Glantz, Michael, Darlix, Amélie, Lombardi, Giuseppe, Krex, Dietmar, Glas, Martin, Reardon, David A., van den Bent, Martin
, Lefranc, Florence, Herrlinger, Ulrich, Razis, Evangelia, Carpentier, Antoine F., Phillips, Samuel, Rudà, Roberta, Wick, Antje
, Tabouret, Emeline, Meyronet, David, Maurage, Claude-Alain, Rushing, Elisabeth, Rapkins, Robert, Bumes, Elisabeth, Hegi, Monika, Weyerbrock, Astrid, Aregawi, Dawit, Gonzalez-Gomez, Christian, Pellerino, Alessia
, Klein, Martin, Preusser, Matthias
, Bendszus, Martin, Golfinopoulos, Vassilis, von Deimling, Andreas, Gorlia, Thierry, Wen, Patrick Y., Reifenberger, Guido und Weller, Michael
(2023)
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419).
European Journal of Cancer 189, S. 112913.
Volltext nicht vorhanden.
Scherm, Angelika, Ippen, Franziska Maria
, Hau, Peter
, Baurecht, Hansjörg
, Wick, Wolfgang
, Gempt, Jens
, Knüttel, Helge, Leitzmann, Michael F. und Seliger, Corinna
(2023)
Targeted therapies in patients with newly diagnosed glioblastoma—A systematic meta‐analysis of randomized clinical trials.
International Journal of Cancer 152 (11), S. 2373-2382.
Volltext nicht vorhanden.
, Hau, Peter
, Baurecht, Hansjörg
, Wick, Wolfgang
, Gempt, Jens
, Knüttel, Helge, Leitzmann, Michael F. und Seliger, Corinna
(2023)
Targeted therapies in patients with newly diagnosed glioblastoma—A systematic meta‐analysis of randomized clinical trials.
International Journal of Cancer 152 (11), S. 2373-2382.
Volltext nicht vorhanden.
Blanco-Carmona, Enrique, Narayanan, Ashwin, Hernandez, Inmaculada, Nieto, Juan C., Elosua-Bayes, Marc, Sun, Xueyuan, Schmidt, Claudia, Pamir, Necmettin, Özduman, Koray, Herold-Mende, Christel, Pagani, Francesca, Cominelli, Manuela, Taranda, Julian, Wick, Wolfgang, von Deimling, Andreas, Poliani, Pietro Luigi, Rehli, Michael, Schlesner, Matthias, Heyn, Holger und Turcan, Şevin
(2023)
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas.
Cell Reports Medicine 4 (11), S. 101249.
Volltext nicht vorhanden.
Hau, Peter
, Frappaz, Didier, Hovey, Elizabeth, McCabe, Martin G.
, Pajtler, Kristian W., Wiestler, Benedikt
, Seidel, Clemens, Combs, Stephanie E., Dirven, Linda, Klein, Martin, Anazodo, Antoinette
, Hattingen, Elke
, Hofer, Silvia, Pfister, Stefan M.
, Zimmer, Claus, Kortmann, Rolf-Dieter, Sunyach, Marie-Pierre, Tanguy, Ronan, Effeney, Rachel, von Deimling, Andreas
, Sahm, Felix
, Rutkowski, Stefan, Berghoff, Anna S., Franceschi, Enrico, Pineda, Estela, Beier, Dagmar
, Peeters, Ellen, Gorlia, Thierry, Vanlancker, Maureen, Bromberg, Jacoline E. C., Gautier, Julien, Ziegler, David S.
, Preusser, Matthias, Wick, Wolfgang und Weller, Michael
(2021)
Development of Randomized Trials in Adults with Medulloblastoma—The Example of EORTC 1634-BTG/NOA-23.
Cancers 13 (14), S. 3451.
van den Bent, Martin J., Tesileanu, C. Mircea S.
, Wick, Wolfgang, Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Erridge, Sarah, Vogelbaum, Michael A., Nowak, Anna K.
, Baurain, Jean Français, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Rogers, Leland, Taal, Walter
, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Caparrotti, Francesca, Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Lim, Elizabeth, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, de Heer, Iris, Aldape, Kenneth, Jenkins, Robert B., Dubbink, Hendrikus Jan, Kros, Johan M., Wesseling, Pieter, Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, French, Pim und Baumert, Brigitta G.
(2021)
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
The Lancet Oncology 22 (6), S. 813-823.
Volltext nicht vorhanden.
, Wick, Wolfgang, Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Erridge, Sarah, Vogelbaum, Michael A., Nowak, Anna K.
, Baurain, Jean Français, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Rogers, Leland, Taal, Walter
, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Caparrotti, Francesca, Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Lim, Elizabeth, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, de Heer, Iris, Aldape, Kenneth, Jenkins, Robert B., Dubbink, Hendrikus Jan, Kros, Johan M., Wesseling, Pieter, Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, French, Pim und Baumert, Brigitta G.
(2021)
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
The Lancet Oncology 22 (6), S. 813-823.
Volltext nicht vorhanden.
Hau, Peter, Dirven, Linda, Luerding, Ralf, Beier, Dagmar, Bumes, Elisabeth, Reinert, Christiane, Seidel, Clemens, Bonsanto, Matteo Mario, Bremer, Michael, Rieken, Stefan, Combs, Stephanie E., Herrlinger, Ulrich, Seliger, Corinna, Kuntze, Holger, Mayer‑Steinacker, Regine, Dieing, Annette, Bartels, Claudius, Schnell, Oliver, Weyerbrock, Astrid, Seidel, Sabine, Grauer, Oliver, Nadji‑Ohl, Minou, Paulsen, Frank
, Weller, Michael und Wick, Wolfgang
(2020)
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study.
Journal of Neuro-Oncology 148, S. 117-130.
Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter
, Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh
, Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert
, Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes
, Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang
, Weller, Michael
, Fimmers, Rolf, Schmid, Matthias
, Hattingen, Elke
, Pietsch, Torsten, Coch, Christoph und Glas, Martin
(2019)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial.
The Lancet 393 (10172), S. 678-688.
Volltext nicht vorhanden.
, Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh
, Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert
, Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes
, Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang
, Weller, Michael
, Fimmers, Rolf, Schmid, Matthias
, Hattingen, Elke
, Pietsch, Torsten, Coch, Christoph und Glas, Martin
(2019)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial.
The Lancet 393 (10172), S. 678-688.
Volltext nicht vorhanden.
van den Bent, Martin J., Baumert, Brigitta, Erridge, Sara C., Vogelbaum, Michael A., Nowak, Anna K.
, Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Baurain, Jean Francais, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Brachman, David G., Taal, Walter, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Weber, Damien C., Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Pascoe, Sarah, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, van Heuvel, Irene, Stupp, Roger, Aldape, Ken, Jenkins, Robert B., Dubbink, Hendrikus Jan, Dinjens, Winand N. M., Wesseling, Pieter
, Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, Wick, Wolfgang und Kros, Johan M.
(2017)
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
The Lancet 390 (10103), S. 1645-1653.
Volltext nicht vorhanden.
, Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Baurain, Jean Francais, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Brachman, David G., Taal, Walter, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Weber, Damien C., Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Pascoe, Sarah, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, van Heuvel, Irene, Stupp, Roger, Aldape, Ken, Jenkins, Robert B., Dubbink, Hendrikus Jan, Dinjens, Winand N. M., Wesseling, Pieter
, Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, Wick, Wolfgang und Kros, Johan M.
(2017)
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
The Lancet 390 (10103), S. 1645-1653.
Volltext nicht vorhanden.
Beier, Dagmar, Proescholdt, Martin, Reinert, Christiane, Pietsch, Torsten, Jones, David T. W.
, Pfister, Stefan M.
, Hattingen, Elke
, Seidel, Clemens, Dirven, Linda, Luerding, Ralf, Reijneveld, Jaap, Warmuth-Metz, Monika, Bonsanto, Matteo, Bremer, Michael, Combs, Stephanie E., Rieken, Stefan, Herrlinger, Ulrich, Kuntze, Holger, Mayer-Steinacker, Regine, Moskopp, Dag, Schneider, Thomas, Beringer, Andreas, Schlegel, Uwe, Stummer, Walter, Welker, Helmut, Weyerbrock, Astrid, Paulsen, Frank, Rutkowski, Stefan, Weller, Michael, Wick, Wolfgang, Kortmann, Rolf-Dieter, Bogdahn, Ulrich und Hau, Peter
(2017)
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Neuro-Oncology 20 (3), S. 400-410.
Volltext nicht vorhanden.
, Pfister, Stefan M.
, Hattingen, Elke
, Seidel, Clemens, Dirven, Linda, Luerding, Ralf, Reijneveld, Jaap, Warmuth-Metz, Monika, Bonsanto, Matteo, Bremer, Michael, Combs, Stephanie E., Rieken, Stefan, Herrlinger, Ulrich, Kuntze, Holger, Mayer-Steinacker, Regine, Moskopp, Dag, Schneider, Thomas, Beringer, Andreas, Schlegel, Uwe, Stummer, Walter, Welker, Helmut, Weyerbrock, Astrid, Paulsen, Frank, Rutkowski, Stefan, Weller, Michael, Wick, Wolfgang, Kortmann, Rolf-Dieter, Bogdahn, Ulrich und Hau, Peter
(2017)
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Neuro-Oncology 20 (3), S. 400-410.
Volltext nicht vorhanden.
Suchorska, Bogdana, Weller, Michael, Tabatabai, Ghazaleh, Senft, Christian
, Hau, Peter, Sabel, Michael C., Herrlinger, Ulrich, Ketter, Ralf, Schlegel, Uwe, Marosi, Christine, Reifenberger, Guido, Wick, Wolfgang, Tonn, Jörg C. und Wirsching, Hans-Georg
(2016)
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial.
Neuro-Oncology 18 (4), S. 549-556.
Volltext nicht vorhanden.
, Hau, Peter, Sabel, Michael C., Herrlinger, Ulrich, Ketter, Ralf, Schlegel, Uwe, Marosi, Christine, Reifenberger, Guido, Wick, Wolfgang, Tonn, Jörg C. und Wirsching, Hans-Georg
(2016)
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial.
Neuro-Oncology 18 (4), S. 549-556.
Volltext nicht vorhanden.
Wick, Wolfgang, Roth, Patrick
, Hartmann, Christian, Hau, Peter, Nakamura, Makoto, Stockhammer, Florian
, Sabel, Michael C., Wick, Antje, Koeppen, Susanne, Ketter, Ralf, Vajkoczy, Peter, Eyupoglu, Ilker, Kalff, Rolf, Happold, Caroline, Galldiks, Norbert, Schmidt-Graf, Friederike, Bamberg, Michael, Reifenberger, Guido, Platten, Michael, von Deimling, Andreas
, Meisner, Christoph
, Wiestler, Benedikt und Weller, Michael
(2016)
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
Neuro-Oncology, now133.
Volltext nicht vorhanden.
, Hartmann, Christian, Hau, Peter, Nakamura, Makoto, Stockhammer, Florian
, Sabel, Michael C., Wick, Antje, Koeppen, Susanne, Ketter, Ralf, Vajkoczy, Peter, Eyupoglu, Ilker, Kalff, Rolf, Happold, Caroline, Galldiks, Norbert, Schmidt-Graf, Friederike, Bamberg, Michael, Reifenberger, Guido, Platten, Michael, von Deimling, Andreas
, Meisner, Christoph
, Wiestler, Benedikt und Weller, Michael
(2016)
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
Neuro-Oncology, now133.
Volltext nicht vorhanden.
Schliesser, Maximilian Georg, Claus, Rainer, Hielscher, Thomas, Grimm, Christiane, Weichenhan, Dieter, Blaes, Jonas, Wiestler, Benedikt, Hau, Peter, Schramm, Johannes, Sahm, Felix, Weiß, Elisa K., Weiler, Markus, Baer, Constance, Schmidt-Graf, Friederike, Schackert, Gabriele, Westphal, Manfred, Hertenstein, Anne, Roth, Patrick
, Galldiks, Norbert, Hartmann, Christian, Pietsch, Torsten, Felsberg, Jörg, Reifenberger, Guido, Sabel, Michael Christoph, Winkler, Frank, von Deimling, Andreas
, Meisner, Christoph, Vajkoczy, Peter, Platten, Michael
, Weller, Michael, Plass, Christoph und Wick, Wolfgang
(2016)
Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Oncotarget 7 (50).
Volltext nicht vorhanden.
, Galldiks, Norbert, Hartmann, Christian, Pietsch, Torsten, Felsberg, Jörg, Reifenberger, Guido, Sabel, Michael Christoph, Winkler, Frank, von Deimling, Andreas
, Meisner, Christoph, Vajkoczy, Peter, Platten, Michael
, Weller, Michael, Plass, Christoph und Wick, Wolfgang
(2016)
Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Oncotarget 7 (50).
Volltext nicht vorhanden.
Weller, Michael, Tabatabai, Ghazaleh, Kästner, Bärbel, Felsberg, Jörg, Steinbach, Joachim P., Wick, Antje, Schnell, Oliver, Hau, Peter, Herrlinger, Ulrich, Sabel, Michael C., Wirsching, Hans-Georg, Ketter, Ralf, Bähr, Oliver, Platten, Michael
, Tonn, Jörg C., Schlegel, Uwe, Marosi, Christine, Goldbrunner, Roland, Stupp, Roger, Homicsko, Krisztian, Pichler, Josef, Nikkhah, Guido, Meixensberger, Jürgen, Vajkoczy, Peter, Kollias, Spyros, Hüsing, Johannes, Reifenberger, Guido und Wick, Wolfgang
(2015)
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.
Clinical Cancer Research 21 (9), S. 2057-2064.
Volltext nicht vorhanden.
, Tonn, Jörg C., Schlegel, Uwe, Marosi, Christine, Goldbrunner, Roland, Stupp, Roger, Homicsko, Krisztian, Pichler, Josef, Nikkhah, Guido, Meixensberger, Jürgen, Vajkoczy, Peter, Kollias, Spyros, Hüsing, Johannes, Reifenberger, Guido und Wick, Wolfgang
(2015)
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.
Clinical Cancer Research 21 (9), S. 2057-2064.
Volltext nicht vorhanden.
Suchorska, Bogdana, Weller, Michael, Tabatabai, Ghazaleh, Senft, Christian
, Hau, Peter, Sabel, Michael, Herrlinger, Ulrich, Ketter, Ralf, Schlegel, Uwe S., Marosi, Christine, Reifenberger, Guido, Wick, Wolfgang, Tonn, Joerg und Wirsching, Hans-Georg
(2015)
Does extent of resection matter in recurrent glioblastoma? Lessons from the DIRECTOR trial.
Journal of Clinical Oncology 33 (15_sup), S. 2041.
Volltext nicht vorhanden.
, Hau, Peter, Sabel, Michael, Herrlinger, Ulrich, Ketter, Ralf, Schlegel, Uwe S., Marosi, Christine, Reifenberger, Guido, Wick, Wolfgang, Tonn, Joerg und Wirsching, Hans-Georg
(2015)
Does extent of resection matter in recurrent glioblastoma? Lessons from the DIRECTOR trial.
Journal of Clinical Oncology 33 (15_sup), S. 2041.
Volltext nicht vorhanden.
Stupp, Roger, Hegi, Monika E
, Gorlia, Thierry, Erridge, Sara C, Perry, James, Hong, Yong-Kil, Aldape, Kenneth D, Lhermitte, Benoit, Pietsch, Torsten, Grujicic, Danica, Steinbach, Joachim Peter, Wick, Wolfgang, Tarnawski, Rafał, Nam, Do-Hyun, Hau, Peter, Weyerbrock, Astrid, Taphoorn, Martin J B, Shen, Chiung-Chyi, Rao, Nalini, Thurzo, László, Herrlinger, Ulrich, Gupta, Tejpal, Kortmann, Rolf-Dieter, Adamska, Krystyna, McBain, Catherine, Brandes, Alba A, Tonn, Joerg Christian, Schnell, Oliver, Wiegel, Thomas, Kim, Chae-Yong, Nabors, Louis Burt
, Reardon, David A, van den Bent, Martin J
, Hicking, Christine, Markivskyy, Andriy, Picard, Martin und Weller, Michael
(2014)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.
The Lancet Oncology 15 (10), S. 1100-1108.
Volltext nicht vorhanden.
, Gorlia, Thierry, Erridge, Sara C, Perry, James, Hong, Yong-Kil, Aldape, Kenneth D, Lhermitte, Benoit, Pietsch, Torsten, Grujicic, Danica, Steinbach, Joachim Peter, Wick, Wolfgang, Tarnawski, Rafał, Nam, Do-Hyun, Hau, Peter, Weyerbrock, Astrid, Taphoorn, Martin J B, Shen, Chiung-Chyi, Rao, Nalini, Thurzo, László, Herrlinger, Ulrich, Gupta, Tejpal, Kortmann, Rolf-Dieter, Adamska, Krystyna, McBain, Catherine, Brandes, Alba A, Tonn, Joerg Christian, Schnell, Oliver, Wiegel, Thomas, Kim, Chae-Yong, Nabors, Louis Burt
, Reardon, David A, van den Bent, Martin J
, Hicking, Christine, Markivskyy, Andriy, Picard, Martin und Weller, Michael
(2014)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.
The Lancet Oncology 15 (10), S. 1100-1108.
Volltext nicht vorhanden.
Nowosielski, Martha, Wiestler, Benedikt, Goebel, Georg, Hutterer, Markus, Schlemmer, Heinz P., Stockhammer, Günther, Wick, Wolfgang, Bendszus, Martin und Radbruch, Alexander
(2014)
Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma.
Neurology 82 (19), S. 1684-1692.
Volltext nicht vorhanden.
Reinert, Christiane
, Kremmler, Lukas, Burock, Susen, Bogdahn, Ulrich, Wick, Wolfgang, Gleiter, Christoph H., Koller, Michael und Hau, Peter
(2014)
Quantitative and qualitative analysis of study-related patient information sheets in randomised neuro-oncology phase III-trials.
European Journal of Cancer 50 (1), S. 150-158.
Volltext nicht vorhanden.
, Kremmler, Lukas, Burock, Susen, Bogdahn, Ulrich, Wick, Wolfgang, Gleiter, Christoph H., Koller, Michael und Hau, Peter
(2014)
Quantitative and qualitative analysis of study-related patient information sheets in randomised neuro-oncology phase III-trials.
European Journal of Cancer 50 (1), S. 150-158.
Volltext nicht vorhanden.
Pflugfelder, Annette, Kochs, Corinna, Blum, Andreas, Capellaro, Marcus, Czeschik, Christina
, Dettenborn, Therese, Dill, Dorothee, Dippel, Edgar, Eigentler, Thomas
, Feyer, Petra, Follmann, Markus, Frerich, Bernhard, Ganten, Maria‐Katharina, Gärtner, Jan
, Gutzmer, Ralf, Hassel, Jessica, Hauschild, Axel, Hohenberger, Peter, Hübner, Jutta, Kaatz, Martin, Kleeberg, Ulrich R., Kölbl, Oliver, Kortmann, Rolf‐Dieter, Krause‐Bergmann, Albrecht, Kurschat, Peter, Leiter, Ulrike
, Link, Hartmut, Loquai, Carmen, Löser, Christoph, Mackensen, Andreas, Meier, Friedegund, Mohr, Peter, Möhrle, Matthias, Nashan, Dorothee, Reske, Sven, Rose, Christian, Sander, Christian, Satzger, Imke, Schiller, Meinhard, Schlemmer, Heinz‐Peter, Strittmatter, Gerhard, Sunderkötter, Cord, Swoboda, Lothar, Trefzer, Uwe, Voltz, Raymond, Vordermark, Dirk, Weichenthal, Michael, Werner, Andreas, Wesselmann, Simone, Weyergraf, Ansgar J., Wick, Wolfgang, Garbe, Claus und Schadendorf, Dirk
(2013)
Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”.
JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11 (s6), S. 1-116.
Volltext nicht vorhanden.
, Dettenborn, Therese, Dill, Dorothee, Dippel, Edgar, Eigentler, Thomas
, Feyer, Petra, Follmann, Markus, Frerich, Bernhard, Ganten, Maria‐Katharina, Gärtner, Jan
, Gutzmer, Ralf, Hassel, Jessica, Hauschild, Axel, Hohenberger, Peter, Hübner, Jutta, Kaatz, Martin, Kleeberg, Ulrich R., Kölbl, Oliver, Kortmann, Rolf‐Dieter, Krause‐Bergmann, Albrecht, Kurschat, Peter, Leiter, Ulrike
, Link, Hartmut, Loquai, Carmen, Löser, Christoph, Mackensen, Andreas, Meier, Friedegund, Mohr, Peter, Möhrle, Matthias, Nashan, Dorothee, Reske, Sven, Rose, Christian, Sander, Christian, Satzger, Imke, Schiller, Meinhard, Schlemmer, Heinz‐Peter, Strittmatter, Gerhard, Sunderkötter, Cord, Swoboda, Lothar, Trefzer, Uwe, Voltz, Raymond, Vordermark, Dirk, Weichenthal, Michael, Werner, Andreas, Wesselmann, Simone, Weyergraf, Ansgar J., Wick, Wolfgang, Garbe, Claus und Schadendorf, Dirk
(2013)
Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”.
JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11 (s6), S. 1-116.
Volltext nicht vorhanden.
Pflugfelder, Annette, Kochs, Corinna, Blum, Andreas, Capellaro, Marcus, Czeschik, Christina
, Dettenborn, Therese, Dill, Dorothee, Dippel, Edgar, Eigentler, Thomas
, Feyer, Petra, Follmann, Markus, Frerich, Bernhard, Ganten, Maria‐Katharina, Gärtner, Jan
, Gutzmer, Ralf, Hassel, Jessica, Hauschild, Axel, Hohenberger, Peter, Hübner, Jutta, Kaatz, Martin, Kleeberg, Ulrich R., Kölbl, Oliver, Kortmann, Rolf‐Dieter, Krause‐Bergmann, Albrecht, Kurschat, Peter, Leiter, Ulrike, Link, Hartmut, Loquai, Carmen, Löser, Christoph, Mackensen, Andreas, Meier, Friedegund, Mohr, Peter, Möhrle, Matthias, Nashan, Dorothee, Reske, Sven, Rose, Christian, Sander, Christian, Satzger, Imke, Schiller, Meinhard, Schlemmer, Heinz‐Peter, Strittmatter, Gerhard, Sunderkötter, Cord, Swoboda, Lothar, Trefzer, Uwe, Voltz, Raymond, Vordermark, Dirk, Weichenthal, Michael, Werner, Andreas, Wesselmann, Simone, Weyergraf, Ansgar J., Wick, Wolfgang, Garbe, Claus und Schadendorf, Dirk
(2013)
S3‐Guideline “Diagnosis, therapy and follow‐up of melanoma” – short version.
JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11 (6), S. 563-602.
Volltext nicht vorhanden.
, Dettenborn, Therese, Dill, Dorothee, Dippel, Edgar, Eigentler, Thomas
, Feyer, Petra, Follmann, Markus, Frerich, Bernhard, Ganten, Maria‐Katharina, Gärtner, Jan
, Gutzmer, Ralf, Hassel, Jessica, Hauschild, Axel, Hohenberger, Peter, Hübner, Jutta, Kaatz, Martin, Kleeberg, Ulrich R., Kölbl, Oliver, Kortmann, Rolf‐Dieter, Krause‐Bergmann, Albrecht, Kurschat, Peter, Leiter, Ulrike, Link, Hartmut, Loquai, Carmen, Löser, Christoph, Mackensen, Andreas, Meier, Friedegund, Mohr, Peter, Möhrle, Matthias, Nashan, Dorothee, Reske, Sven, Rose, Christian, Sander, Christian, Satzger, Imke, Schiller, Meinhard, Schlemmer, Heinz‐Peter, Strittmatter, Gerhard, Sunderkötter, Cord, Swoboda, Lothar, Trefzer, Uwe, Voltz, Raymond, Vordermark, Dirk, Weichenthal, Michael, Werner, Andreas, Wesselmann, Simone, Weyergraf, Ansgar J., Wick, Wolfgang, Garbe, Claus und Schadendorf, Dirk
(2013)
S3‐Guideline “Diagnosis, therapy and follow‐up of melanoma” – short version.
JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11 (6), S. 563-602.
Volltext nicht vorhanden.
Wick, Wolfgang, Platten, Michael, Meisner, Christoph, Felsberg, Jörg, Tabatabai, Ghazaleh, Simon, Matthias, Nikkhah, Guido, Papsdorf, Kirsten, Steinbach, Joachim P., Sabel, Michael, Combs, Stephanie E., Vesper, Jan, Braun, Christian, Meixensberger, Jürgen, Ketter, Ralf, Mayer-Steinacker, Regine, Reifenberger, Guido und Weller, Michael
(2012)
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.
The lancet oncology 13 (7), S. 707-715.
Volltext nicht vorhanden.
Grauer, Oliver, Pascher, Christina, Hartmann, Christian, Zeman, Florian, Weller, Michael, Proescholdt, Martin, Brawanski, Alexander, Pietsch, Thorsten, Wick, Wolfgang, Bogdahn, Ulrich und Hau, Peter
(2011)
Erratum to: Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05).
Journal of Neuro-Oncology 105 (3), S. 671.
Volltext nicht vorhanden.
Grauer, Oliver, Pascher, Christina, Hartmann, Christian, Zeman, Florian, Weller, Michael, Proescholdt, Martin A., Brawanski, Alexander, Pietsch, Thorsten, Wick, Wolfgang, Bogdahn, Ulrich und Hau, Peter
(2011)
Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05).
Journal of neuro-oncology 104 (3), S. 801-809.
Volltext nicht vorhanden.
Wick, Antje, Pascher, Christina, Wick, Wolfgang, Jauch, Tanja, Weller, Michael, Bogdahn, Ulrich und Hau, Peter
(2009)
Rechallenge with temozolomide in patients with recurrent gliomas.
Journal of neurology 256 (5), S. 734-741.
Volltext nicht vorhanden.
